Comparison effect of melatonin and zinc in optimization of sleep disorder in cirrhotic patients
Phase 3
Not yet recruiting
- Conditions
- Patients with diagnosis of cirrhosis.Unspecified cirrhosis of liverK74.60
- Registration Number
- IRCT20121021011192N18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Patients with diagnosis of cirrhosis on the basis of doing liver biopsy obtaining written informed consent
Exclusion Criteria
Patients with previous history of allergy to melatonin or zinc
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie melatonin and zinc's effects on sleep disorders in cirrhotic patients?
How does melatonin compare to standard-of-care treatments for sleep disorders in liver cirrhosis patients?
Are there specific biomarkers that predict response to melatonin or zinc in cirrhotic sleep disorders?
What are the potential adverse events associated with melatonin and zinc in cirrhotic patients?
What combination therapies or alternative drugs show promise for managing sleep disorders in liver cirrhosis?